(Q36107258)

12 August 2017

1 reference

title

Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects? (English)

1 reference

12 August 2017

0 references

1

Eva Carro

1 reference

12 August 2017

author name string

Ignacio Torres-Aleman

series ordinal

2

1 reference

12 August 2017

language of work or name

1 reference

1 January 2004

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

79-86

1 reference

Mild cognitive impairment in older people.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

New frontiers in Alzheimer's disease genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Serum growth factors and neuroprotective surveillance: focus on IGF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Insulin-Like growth factor I: implications in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

The role of the insulin-like growth factors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Insulin-like growth factors (IGFs): implications for aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Normal growth and development in the absence of hepatic insulin-like growth factor I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Is there a future for vaccination as a treatment for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Cerebral hemorrhage after passive anti-Abeta immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Inflammation and therapeutic vaccination in CNS diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

Regulation of neuronal survival by the serine-threonine protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.1.79

21 January 2018

Identifiers

DOI

10.1586/14737175.4.1.79

1 reference

12 August 2017

1 reference